266 related articles for article (PubMed ID: 17550317)
1. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Yee DS; Narula N; Ramzy I; Boker J; Ahlering TE; Skarecky DW; Ornstein DK
Arch Pathol Lab Med; 2007 Jun; 131(6):902-8. PubMed ID: 17550317
[TBL] [Abstract][Full Text] [Related]
2. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
3. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens.
Helpap B
Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
[TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L
Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434
[TBL] [Abstract][Full Text] [Related]
9. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
10. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial.
Bullock MJ; Srigley JR; Klotz LH; Goldenberg SL
Am J Surg Pathol; 2002 Nov; 26(11):1400-13. PubMed ID: 12409716
[TBL] [Abstract][Full Text] [Related]
11. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Kang JS; Calvo BF; Maygarden SJ; Caskey LS; Mohler JL; Ornstein DK
Clin Cancer Res; 2002 Jan; 8(1):117-23. PubMed ID: 11801547
[TBL] [Abstract][Full Text] [Related]
13. Prostatic adenocarcinoma with glomeruloid features.
Pacelli A; Lopez-Beltran A; Egan AJ; Bostwick DG
Hum Pathol; 1998 May; 29(5):543-6. PubMed ID: 9596281
[TBL] [Abstract][Full Text] [Related]
14. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels.
Lefkowitz GK; Taneja SS; Brown J; Melamed J; Lepor H
J Urol; 2002 Oct; 168(4 Pt 1):1415-8. PubMed ID: 12352407
[TBL] [Abstract][Full Text] [Related]
15. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
16. Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy.
Izumi K; Li Y; Zheng Y; Gordetsky J; Yao JL; Miyamoto H
Hum Pathol; 2012 Nov; 43(11):1991-2000. PubMed ID: 22617231
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of conventional histologic parameters and biologic factors in prostatic needle biopsy are useful to distinguish paramalignant from malignant disease.
Silva LC; Saldiva PH; Ellinger F; Filho BL; Capelozzi VL; Antonangelo L
Pathol Res Pract; 2004; 200(9):599-608. PubMed ID: 15497772
[TBL] [Abstract][Full Text] [Related]
19. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.
Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
Willman JH; Holden JA
Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]